B
IBB icon

Bellecapital’s iShares Biotechnology ETF IBB Stock Holding History

Bellecapital’s Portfolio IBB Stock Details IBB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		– Sell
-2,670
Closed -$314K – 194
2022
Q2 		$314K Hold
2,670
– – 0.09% 150
2022
Q1 		$348K Hold
2,670
– – 0.11% 142
2021
Q4 		$407K Buy
+2,670
New +$413K 0.12% 137
2020
Q4 		– Sell
-44,039
Closed -$5.96M – 189
2020
Q3 		$5.96M Sell
44,039
-790
-2% -$107K 2.73% 8
2020
Q2 		$6.13M Buy
44,829
+658
+1% +$83.9K 2.87% 9
2020
Q1 		$4.76M Buy
44,171
+3,790
+9% +$436K 3.04% 8
2019
Q4 		$4.87M Sell
40,381
-2,014
-5% -$225K 2.5% 11
2019
Q3 		$4.22M Hold
42,395
– – 2.53% 12
2019
Q2 		$4.63M Sell
42,395
-70
-0.2% -$7.45K 2.88% 12
2019
Q1 		$4.75M Sell
42,465
-6,498
-13% -$713K 3.02% 12
2018
Q4 		$4.72M Buy
48,963
+928
+2% +$98.5K 3.37% 11
2018
Q3 		$5.86M Sell
48,035
-7,075
-13% -$833K 3.84% 8
2018
Q2 		$6.05M Buy
55,110
+17,760
+48% +$1.9M 4.37% 5
2018
Q1 		$3.99M Sell
37,350
-18,919
-34% -$2.1M 3.73% 9
2017
Q4 		$6.01M Buy
56,269
+25,564
+83% +$2.73M 4.86% 5
2017
Q3 		$3.41M Sell
30,705
-27,570
-47% -$2.95M 4.02% 8
2017
Q2 		$6.02M Sell
58,275
-3,468
-6% -$342K 5.28% 4
2017
Q1 		$6.04M Sell
61,743
-1,119
-2% -$107K 5.58% 2
2016
Q4 		$5.56M Buy
62,862
+18,069
+40% +$1.64M 4.95% 4
2016
Q3 		$4.32M Sell
44,793
-20,994
-32% -$2M 4.81% 5
2016
Q2 		$5.64M Buy
+65,787
New +$5.9M 6.18% 2

Other funds holding IBB

Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $672B AUM 33.48% 1-Year Est. Return
Citigroup
Citigroup New York $303B AUM 53.02% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
Jane Street
Jane Street New York $1.21T AUM 78.12% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return
BNP Paribas Financial Markets
BNP Paribas Financial Markets Paris, France $289B AUM 60.46% 1-Year Est. Return
CB
Commerce Bank Kansas City, Missouri $22.8B AUM 28.56% 1-Year Est. Return

Bellecapital's IBB Position: Q3 2022 in Review

Bellecapital sold out of iShares Biotechnology ETF (IBB) in Q3 2022, closing a stake of 2,670 shares — an estimated $314K sold.

Bellecapital first reported a position in IBB in Q2 2016 and held it in 21 quarters. The position peaked at $6.13M in Q2 2020. 829 funds tracked by Wall St. Rank hold IBB as of Q3 2022.

  • Bellecapital reported no remaining iShares Biotechnology ETF position as of Q3 2022 after selling out during the quarter.
  • Bellecapital sold 2,670 iShares Biotechnology ETF shares in Q3 2022, an estimated $314K.
  • Bellecapital first reported a position in iShares Biotechnology ETF in Q2 2016 and held it in 21 quarters.
  • Bellecapital's iShares Biotechnology ETF position peaked at $6.13M in Q2 2020.
  • 829 funds tracked by Wall St. Rank held iShares Biotechnology ETF as of Q3 2022.

Based on Bellecapital's 13F filing for Q3 2022, filed 7 Nov 2022.